BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24809224)

  • 21. [The clinical significance of MDR-1 gene expression in the hemopoietic cells of patients with acute leukemias in different phases of the disease].
    Bykova TV; Sominskaia AA; Zaritskiĭ AIu; Stiuf IIu; Medvedeva BV; Anikina NA; Afanas'ev BV
    Ter Arkh; 1998; 70(7):11-4. PubMed ID: 9742628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ABCA3 as a possible cause of drug resistance in childhood acute myeloid leukemia.
    Steinbach D; Gillet JP; Sauerbrey A; Gruhn B; Dawczynski K; Bertholet V; de Longueville F; Zintl F; Remacle J; Efferth T
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4357-63. PubMed ID: 16857811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. De novo polycythaemia vera arising 5 years following acute myeloid leukemia remission: suggestion of a chemotherapy resistant JAK2 clone.
    Portell CA; Sekeres MA; Rogers HJ; Tiu RV
    Br J Haematol; 2012 Apr; 157(2):266-7. PubMed ID: 22150289
    [No Abstract]   [Full Text] [Related]  

  • 24. Choline-magnesium trisalicylate modulates acute myelogenous leukemia gene expression during induction chemotherapy.
    Medina D; David K; Lin Y; Schaar D; Patel V; Gharibo M; Bannerji R; Walton K; Aisner J; Rabson AB; Strair R
    Leuk Lymphoma; 2017 May; 58(5):1227-1230. PubMed ID: 27659510
    [No Abstract]   [Full Text] [Related]  

  • 25. Q141K polymorphism of ABCG2 protein is associated with poor prognosis in adult acute myeloid leukemia treated with idarubicin-based chemotherapy.
    Tiribelli M; Fabbro D; Franzoni A; Fanin R; Damante G; Damiani D
    Haematologica; 2013 Mar; 98(3):e28-9. PubMed ID: 23065526
    [No Abstract]   [Full Text] [Related]  

  • 26. ATP-binding-cassette transporters in hematopoietic stem cells and their utility as therapeutical targets in acute and chronic myeloid leukemia.
    Raaijmakers MH
    Leukemia; 2007 Oct; 21(10):2094-102. PubMed ID: 17657220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of stem cell markers in multidrug resistance mediated by ABC transporters.
    Tiwari AK; An X; Chen ZS
    Leuk Res; 2010 Jun; 34(6):696-7. PubMed ID: 20061021
    [No Abstract]   [Full Text] [Related]  

  • 28. ABC transporters are predictors of treatment failure in acute myeloid leukaemia.
    Cerovska E; Salek C; Kundrat D; Sestakova S; Pesek A; Brozinova I; Belickova M; Remesova H
    Biomed Pharmacother; 2024 Jan; 170():115930. PubMed ID: 38039756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutant DNMT3A clone evading chemotherapy and infiltrating central nervous system in a patient with molecularly good-risk acute myeloid leukemia.
    Chen YY; Huang CE; Chou HJ; Tsai PS; Lu CH; Chen MF; Lee KD; Chen PT; Lung J; Chen CC
    Ann Hematol; 2014 Aug; 93(8):1441-2. PubMed ID: 24337413
    [No Abstract]   [Full Text] [Related]  

  • 30. [The clinical significance of multidrug resistance associated protein(MRP) gene expression in acute leukemia].
    Wang F; Dong Z; Luo J
    Zhonghua Xue Ye Xue Za Zhi; 1998 Feb; 19(2):63-6. PubMed ID: 10921103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BCRP mRNA expression v. clinical outcome in 40 adult AML patients.
    Uggla B; Ståhl E; Wågsäter D; Paul C; Karlsson MG; Sirsjö A; Tidefelt U
    Leuk Res; 2005 Feb; 29(2):141-6. PubMed ID: 15607361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR1 and MRP together with 1-beta-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia.
    Schuurhuis GJ; Broxterman HJ; Ossenkoppele GJ; Baak JP; Eekman CA; Kuiper CM; Feller N; van Heijningen TH; Klumper E; Pieters R
    Clin Cancer Res; 1995 Jan; 1(1):81-93. PubMed ID: 9815890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer.
    Kovalev AA; Tsvetaeva DA; Grudinskaja TV
    Exp Oncol; 2013 Dec; 35(4):287-90. PubMed ID: 24382439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesenchymal stromal cells confer chemoresistance to myeloid leukemia blasts through Side Population functionality and ABC transporter activation.
    Boutin L; Arnautou P; Trignol A; Ségot A; Farge T; Desterke C; Soave S; Clay D; Raffoux E; Sarry JE; Malfuson JV; Lataillade JJ; Le Bousse-Kerdilès MC; Anginot A
    Haematologica; 2020 Apr; 105(4):987-9998. PubMed ID: 31289201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of changes in serum endostatin and fibroblast growth factor 19 on the chemotherapeutic sensitivity in acute myeloid leukemia patients.
    Su YZ; Wang CB; Zhou Y; Sun NT
    Genet Mol Res; 2015 May; 14(2):5181-7. PubMed ID: 26125711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia.
    Steinbach D; Sell W; Voigt A; Hermann J; Zintl F; Sauerbrey A
    Leukemia; 2002 Aug; 16(8):1443-7. PubMed ID: 12145683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. c-MYC oncoprotein dictates transcriptional profiles of ATP-binding cassette transporter genes in chronic myelogenous leukemia CD34+ hematopoietic progenitor cells.
    Porro A; Iraci N; Soverini S; Diolaiti D; Gherardi S; Terragna C; Durante S; Valli E; Kalebic T; Bernardoni R; Perrod C; Haber M; Norris MD; Baccarani M; Martinelli G; Perini G
    Mol Cancer Res; 2011 Aug; 9(8):1054-66. PubMed ID: 21693596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alleviation of the drug-resistant phenotype in idarubicin and cytosine arabinoside double-resistant acute myeloid leukemia cells by indomethacin.
    Song JH; Kim SH; Kim HJ; Hwang SY; Kim TS
    Int J Oncol; 2008 Apr; 32(4):931-6. PubMed ID: 18360721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversing multidrug resistance (MDR1, ABCB1) in acute myeloid leukemia: back to the ABCs.
    Rund D
    Leuk Lymphoma; 2013 Nov; 54(11):2347-8. PubMed ID: 23527524
    [No Abstract]   [Full Text] [Related]  

  • 40. Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein.
    Stam RW; van den Heuvel-Eibrink MM; den Boer ML; Ebus ME; Janka-Schaub GE; Allen JD; Pieters R
    Leukemia; 2004 Jan; 18(1):78-83. PubMed ID: 14574327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.